HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD

Overview

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 18 active FDA Type II Drug Master Files, covering 5-METHOXYURIDINE-5'-TRIPHOSPHATE TRISODIUM SALT; ACARBOSE USP; CAP-2 (7413 SODIUM); DAPTOMYCIN; FONDAPARINUX SODIUM; INSULIN ASPART.

API / Drug Master Files

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD holds 18 active (22 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• INSULIN ASPARTActive2026-01-29
• INSULIN DEGLUDECActive2025-09-30
• VOCLOSPORINActive2025-09-26
• SEMAGLUTIDE (PROCESS II)Active2025-01-28
• LEUCOVORIN CALCIUMActive2023-09-27
• CAP-2 (7413 SODIUM)Active2023-08-29
• 5-METHOXYURIDINE-5'-TRIPHOSPHATE TRISODIUM SALTActive2023-08-25
• SEMAGLUTIDEActive2023-07-19
• ACARBOSE USPActive2022-07-20
• FONDAPARINUX SODIUMActive2020-04-29
• DAPTOMYCINActive2019-09-25
• TACROLIMUS USPActive2016-12-03
• FONDAPARINUX SODIUMActive2014-08-26
• PANTOPRAZOLE SODIUMActive2011-11-10
• MUPIROCIN CALCIUMActive2011-03-08

Showing 15 of 22 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.